A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PVRI / pulmonary vascular resistance index

[Related PubMed/MEDLINE]
Total Number of Papers: 227
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PVRI  (>> Co-occurring Abbreviation)
Long Form:   pulmonary vascular resistance index
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Reduced pulmonary vascular reserve during stress echocardiography in confirmed pulmonary hypertension and patients at risk of overt pulmonary hypertension. AcT, CO, ESE, PH, sPAP, TRV
2019 Acute Hemodynamic Changes after Single Administration of Udenafil in Pulmonary Arterial Hypertension: a Phase IIa Study. CI, mPAP, MSAP, PAH, PAWP, PDE5i
2019 Differences in pulmonary arterial flow hemodynamics between children and adults with pulmonary arterial hypertension as assessed by 4D-flow CMR studies. EL, LPA
2019 Effects of vasopressin during a pulmonary hypertensive crisis induced by acute hypoxia inaratmodel of pulmonary hypertension. CI, MBP, MCT, PHC, RVSP, SBP
2019 Evaluation of Macitentan in Patients With Eisenmenger Syndrome. CL
2019 Impact of norepinephrine on right ventricular afterload and function in septic shock-a strain echocardiography study. Epa, MAP, RV
2019 Polysplenia Syndrome as a Risk Factor for Early Progression of Pulmonary Hypertension. AVSD, CHD, mPAP, PH
2019 Pulmonary haemodynamics and right ventricular function in cemented vs uncemented total hip arthroplasty-A randomized trial. BCIS, MAP, PAP, RV, RVEF
2019 Right ventricular-vascular coupling ratio in pediatric pulmonary arterial hypertension: A comparison between cardiac magnetic resonance and right heart catheterization measurements. mPAP, mRAP, PAH, RV, VVCR, VVCRCMR, VVCRRHC, WHO-FC
10  2019 Transfusion of standard-issue packed red blood cells induces pulmonary vasoconstriction in critically ill patients after cardiac surgery-A randomized, double-blinded, clinical trial. PAP, PRBCs
11  2019 Ventricular-ventricular interaction variables correlate with surrogate variables of clinical outcome in children with pulmonary hypertension. FC, LV, LVEF, LVEI, NT-proBNP, NYHA, PH, RV
12  2018 Acute Effect of Inhaled Iloprost in Children with Pulmonary Arterial Hypertension Associated with Simple Congenital Heart Defects. CHD, PAH
13  2018 Acute hemodynamic effects of intravenous adenosine in patients with associated pulmonary arterial hypertension: Comparison with intravenous epoprostenol. BP, CI, mPAP, PAH
14  2018 Effective shunt closure for pulmonary hypertension and liver dysfunction in congenital portosystemic venous shunt. CPSVS, PAH
15  2018 The efficiency of endothelin receptor antagonist bosentan for pulmonary arterial hypertension associated with congenital heart disease: A systematic review and meta-analysis. 6MWD, AEs, BDIs, mPAP, PAH-CHD, WHO-FC
16  2018 Venous congestion and pulmonary vascular function in Fontan circulation: Implications for prognosis and treatment. CVP
17  2017 Circulating miRNAs in Pediatric Pulmonary Hypertension Show Promise as Biomarkers of Vascular Function. iNO, RHC
18  2017 Comparison of Levosimendan versus Dobutamine in Patients with Moderate to Severe Left Ventricular Dysfunction Undergoing Off-pump Coronary Artery Bypass Grafting: A Randomized Prospective Study. CI, HR, ICU, LV, LVSWI, MAP, OPCAB, PCWP, RVSWI, SVRI
19  2017 Efficacy and safety of oral sildenafil in children with Down syndrome and pulmonary hypertension. CI, mPAP, STARTS-1
20  2017 First-in-child use of the oral selective prostacyclin IP receptor agonist selexipag in pulmonary arterial hypertension. LVEDP, PAH, PAP, RAP, RV, RVEDP, WHO
21  2017 Hemodynamic Evaluation of Children with Persistent or Recurrent Pulmonary Arterial Hypertension Following Complete Repair of Congenital Heart Disease. ACh, AVT, CHD, IPAH, PAH, PAH-CHD, PEF, PFR
22  2017 Hemodynamics of Fontan Failure: The Role of Pulmonary Vascular Disease. ---
23  2017 Load Adaptability in Patients With Pulmonary Arterial Hypertension. PAH, RV, RVESAI
24  2017 Portopulmonary hypertension in children: a rare but potentially lethal and under-recognized disease. IQR, mPAP, PAH, POPH
25  2017 Pulmonary vascular resistance index during coronary artery bypass surgery with aprotinin. CPB
26  2017 Semi-quantitative assessment of pulmonary arterial hypertension associated with congenital heart disease through myocardial perfusion imaging. 99mTc-MIBI, AUC, CHD, CI, CO, MPI, PAH, PAH-CHD, PAP, PVR, RHC, ROC, RVSV, SPO2, T/B, TPR, TPRI
27  2016 Haemodynamic characterisation and heart catheterisation complications in children with pulmonary hypertension: Insights from the Global TOPP Registry (tracking outcomes and practice in paediatric pulmonary hypertension). CI, GA, HC, PH
28  2016 Hemodynamic response to ketamine in children with pulmonary hypertension. CI, HR, MAP, mPAP, PAOP, PVR, RAP, RVEDP, SVRI
29  2015 Adrenomedullin induces pulmonary vasodilation but does not attenuate pulmonary hypertension in a sheep model of acute pulmonary embolism. APE, mPAP
30  2015 Associations of circulating natriuretic peptides with haemodynamics in precapillary pulmonary hypertension. CI, PAPm, PH, RAP
31  2015 Cardiac catheterization in children with pulmonary hypertensive vascular disease. mean PAp, PAH, PH
32  2015 Elevated pre-transplant pulmonary vascular resistance is not associated with mortality in children without congenital heart disease: a multicenter study. CHD
33  2015 Oxidative stress and nitric oxide signaling related biomarkers in patients with pulmonary hypertension: a case control study. ADMA, BAP, d-ROMs, MDA, mPAP, NO, OS, PH, SOD
34  2015 Pulmonary Hypertension an Independent Risk Factor for Death in Intensive Care Unit: Correlation of Hemodynamic Factors with Mortality. APACHE, CI, CI, PASP, PH, RFI, RV, SOFA
35  2015 Tissue Doppler Imaging Measures Correlate Poorly with Left Ventricular Filling Pressures in Pediatric Cardiomyopathy. LVFPs, TDI
36  2014 Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia. IIP, PH
37  2014 Cardiopulmonary bypass decreases pulmonary vascular resistance index after coronary artery bypass surgery. CPB
38  2014 Dynamic contrast-enhanced magnetic resonance imaging in patients with pulmonary arterial hypertension. AUC, CI, DCE, FWHM, MR, PAH, PTT
39  2014 Effect of lornoxicam in lung inflammatory response syndrome after operations for cardiac surgery with cardiopulmonary bypass. A-a, CI, EC, LVSWI, MMP-3, RVSWI, SVRI
40  2014 Effect of preoperative oral sildenafil on severe pulmonary artery hypertension in patients undergoing mitral valve replacement. CPB, ICU, mPAP, PAC, RV, RVSP
41  2014 Flow characteristics of the proximal pulmonary arteries and vena cava in patients with chronic thromboembolic pulmonary hypertension: correlation between 3.0 T phase-contrast MRI and right heart catheterization. MRI
42  2014 Patients with congenital systemic-to-pulmonary shunts and increased pulmonary vascular resistance: what predicts postoperative survival? PVRIO
43  2014 The use of oral sildenafil for management of right ventricular dysfunction after pediatric heart transplantation. WU
44  2014 [Cardiac catheterization and pulmonary vasoreactivity testing in children with idiopathic pulmonary arterial hypertension]. IPAH, mPAP
45  2014 [Effect of verapamil and nitroglycerin on transplanted lung function in canines]. Cdyn, MDA, mPAP, PIP, SOD
46  2014 [Effects of hyperoncotic cardiopulmonary bypass prime on extravascular lung water and cardiopulmonary function in patients undergoing coronary artery bypass surgery]. CABG, CI, COP, EVLW, HES, MAP, PAP, PCWP, SVRI
47  2013 A practical method of measuring oxygen consumption in children with complex mixing circulations by the use of thermodilution cardiac output studies. BDCPA
48  2013 Acute effect of sildenafil on central hemodynamics in mechanically ventilated patients with WHO group III pulmonary hypertension and right ventricular failure necessitating administration of dobutamine. PH, RVSWI
49  2013 Doppler tissue imaging provides an estimate of pulmonary arterial pressure in children with pulmonary hypertension due to congenital intracardiac shunts. DTI, PAPmean, PW, TS
50  2013 Inflammatory activation after experimental cardiac tamponade. MAP, SMA
51  2013 Protective effects of penehyclidine hydrochloride on acute lung injury caused by severe dichlorvos poisoning in swine. AChE, AI, CI, EVLWI, PHC, PVPI
52  2013 Regional and global biventricular function in pulmonary arterial hypertension: a cardiac MR imaging study. LL, LV, MR, PAH, PAP, RV
53  2013 [Effects of early mechanical ventilation on oxygenation and hemodynamics in acute high altitude pulmonary edema patients complicated by acute respiratory distress syndrome]. ARDS, CI, HAPE, HR, mPAP, PAWP, RAP, RVSWI
54  2013 [Study of changes in extravascular lung water index of patients suffered from H7N9 avian influenza with acute respiratory distress syndrome]. ARDS, CI, CVP, EVLWI, PEEP, PiCCO, SVRI
55  2012 Estimation of endothelin-mediated vasoconstriction in acute pulmonary thromboembolism. APTE, FMS, Ppa, Pw
56  2012 Furegrelate, a thromboxane synthase inhibitor, blunts the development of pulmonary arterial hypertension in neonatal piglets. CH, CT, PAH
57  2012 Increased B-type natriuretic peptide during liver transplantation: relationship to invasively measured hemodynamic parameters. BNP, MELD, OR, PCWP, RVEDVI
58  2012 Inhaled NO and sildenafil combination in cardiac surgery patients with out-of-proportion pulmonary hypertension: acute effects on postoperative gas exchange and hemodynamics. iNO, mPAP
59  2012 Intramedullary nailing of femoral shaft fractures in polytraumatized patients. a longitudinal, prospective and observational study of the procedure-related impact on cardiopulmonary- and inflammatory responses. ALI, ARDS, IL-10, IL-6, IMN, ISS, MOF, PA, SIRS, TNF-alpha
60  2012 Is pulmonary vascular resistance index predictive of exercise tolerance in adult patients with idiopathic pulmonary arterial hypertension. ---
61  2012 Losartan exerts no protective effects against acute pulmonary embolism-induced hemodynamic changes. ACE, APE, mPAP
62  2012 Perioperative assessment of terlipressin infusion during living donor liver transplantation. ICU, LDLT, SVRI
63  2012 Right ventriculo-arterial coupling in pulmonary hypertension: a magnetic resonance study. CMR, ESV, mPAP, PA, PCWP, RHC, SV
64  2012 RV dysfunction in pulmonary hypertension is independently related to pulmonary artery stiffness. PA, PH, RV, RVMI, RVSWI
65  2012 Unidirectional valved patch closure of ventricular septal defects with severe pulmonary arterial hypertension. PAH, UVP, VSD
66  2012 What is high risk? Redefining elevated pulmonary vascular resistance index in pediatric heart transplantation. 30-DM, OHT, OR, PVRId, ROC
67  2011 Effect of N-acetylcysteine on pulmonary function in patients undergoing off-pump coronary artery bypass surgery. LV, NAC, OPCAB
68  2011 Efficacy and safety of high dose generic sildenafil in Thai patients with pulmonary arterial hypertension. IPAH, PAH, PDE-5
69  2011 Increased preoperative thrombin generation and low protein S level associated with unfavorable postoperative hemodynamics after coronary artery bypass grafting. APC, CABG, SVRI
70  2011 Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials. 6MWD, HR, HR 2.44, NYHA FC, PAH
71  2011 Pulsatile pulmonary perfusion with oxygenated blood ameliorates pulmonary hemodynamic and respiratory indices in low-risk coronary artery bypass patients. BAL, CABG, CI, CPB, ICU, PAP, PCWP, PPP
72  2011 Sildenafil improves the beneficial hemodynamic effects exerted by atorvastatin during acute pulmonary thromboembolism. APT, MMPs, mPAP
73  2011 [Adenosine for pulmonary vasodilator testing in children with idiopathic pulmonary arterial hypertension]. IPAH, mPAP, PCWP
74  2011 [Clinical efficacy of sildenafil in interstitial pneumonia with pulmonary hypertension]. BDI, CVD-IP, IP, mPAP, MRC, PH, QOL, SGRQ, SWT, UIP
75  2010 Acute hemodynamic effects of inhaled nitroglycerine, intravenous nitroglycerine, and their combination with intravenous dobutamine in patients with secondary pulmonary hypertension. iNTG, IV DOB, IV NTG, mPAP, PAH
76  2010 Assessment of pulmonary hypertension in the pediatric catheterization laboratory: current insights from the Magic registry. GA, iNO, IPAH, MAGIC, mPAP, PH
77  2010 Clinical relevance of ventilation during cardiopulmonary bypass in the prevention of postoperative lung dysfunction. ACh, CABG, CPB, LOS, mPAP, PEEP
78  2010 Effect of the alveolar recruitment manoeuvre on haemodynamic parameters in patients with acute respiratory distress syndrome: relationship with oxygenation. ARM, mPAP, RVSWI
79  2010 Effects of repeat bolus ethanol injections on cardiopulmonary hemodynamic changes during embolotherapy of arteriovenous malformations of the extremities. AV, PAP
80  2010 Hemodynamic effects of inducible nitric oxide synthase inhibition combined with sildenafil during acute pulmonary embolism. APE, iNOS, mPAP, NO, TBARS
81  2010 Hemodynamic responses to etomidate in pediatric patients with congenital cardiac shunt lesions. HR, mPAP, PAWP, Qp, RAP, SMAP, SVRI
82  2010 Hemodynamics in the immediate post-transplantation period in alcoholic and viral cirrhosis. CI, CVP, HR, MAP, PAP, PCWP, SVRI
83  2010 High-dose glucose-insulin-potassium has hemodynamic benefits and can improve cardiac remodeling in acute myocardial infarction treated with primary percutaneous coronary intervention: From a randomized controlled study. AMI, PCI, SVRI
84  2010 Inhaled nitroglycerin versus inhaled milrinone in children with congenital heart disease suffering from pulmonary artery hypertension. WU
85  2010 Lung transplantation in children with idiopathic pulmonary arterial hypertension. IPAH
86  2010 Pulmonary vascular dysfunction is associated with poor outcomes in patients with acute lung injury. ALI, ICU, PA, TPG
87  2010 Pulmonary vasoreactivity predicts long-term outcome in patients with Eisenmenger syndrome receiving bosentan therapy. CHD, PAH
88  2010 Vasopressin intravenous infusion causes dose dependent adverse cardiovascular effects in anesthetized dogs. AVP, CI, HR, MAP, SVRI
89  2010 [Inhaled iloprost during acute pulmonary vasodilator testing for preoperative assessment of surgical operability of congenital heart disease with severe pulmonary hypertension]. CHD, mPAP, PH
90  2010 [Vasopressin intravenous infusion causes dose dependent adverse cardiovascular effects in anesthetized dogs]. AVP, CI, HR, MAP, SVRI
91  2008 Aortopulmonary window in adults: diagnosis and treatment of late-presenting patients. ---
92  2008 Comparative outcome of bidirectional Glenn shunt in patients with pulmonary vascular resistance > or = 3.5 woods units versus < 3.5 woods units. BDG, WU
93  2008 Human atrial natriuretic peptide prevents the increase in pulmonary artery pressure associated with aortic unclamping during abdominal aortic aneurysmectomy. hANP, mPAP, SA
94  2008 Performance of cavopulmonary palliation at elevated altitude: midterm outcomes and risk factors for failure. BDG, PAP, TPG
95  2008 Primary nonfunction: timing retransplantation versus hemodynamic parameters and kidney function. ALF, CI, HR, MAP, MARS, OLT, PNF, SVRI
96  2008 The effect of diffuse pulmonary fibrosis on the reliability of CT signs of pulmonary hypertension. CT, mPAP, PA, PH, TLC
97  2008 Twenty-year experience with heart transplantation for infants and children with restrictive cardiomyopathy: 1986-2006. PA, PVR, RCM
98  2008 [The hemodynamic investigation of refractory septic shock-related cardiac dysfunction]. CI, CO, CVP, PAC, PAOP, PAP, SVRI
99  2007 A role for matrix metalloproteinase-9 in the hemodynamic changes following acute pulmonary embolism. APE, MMPs, mPAP
100  2007 Aminoguanidine produces beneficial haemodynamic effects in a canine model of acute pulmonary thromboembolism. APT, iNOS, mPAP, NO